SCHEMBL24814392

SCHEMBL24814392

O=C(CS(=O)(=O)c1nccs1)N1Cc2cccc(F)c2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP8 Q6V1X1 2/20 0.41
▸ DPP9 Q86TI2 2/20 0.41
▸ DPP7 Q9UHL4 2/20 0.41
▸ TRAP1 Q12931 8/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ HSP90B1 P14625 3/20 0.38
▸ MAPT P10636 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ P2RX7 Q99572 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986896 1.00 DPP8 (0.41) DPP8DPP9DPP7TRAP1NAMPT
SCHEMBL24815669 0.86 SMN1; SMN2 (0.42) NAMPTLMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL29986905 0.86 SMN1; SMN2 (0.42) NAMPTLMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL24814740 0.84 NLRP3 (0.35) DPP8DPP9NAMPTSMN1; SMN2NPC1
SCHEMBL24817122 0.80 NAMPT (0.44) DPP8DPP9DPP7NAMPT
SCHEMBL29987237 0.78 SMN1; SMN2 (0.53) DPP8DPP9DPP7TRAP1HSP90B1
SCHEMBL24814455 0.78 SMN1; SMN2 (0.53) DPP8DPP9DPP7TRAP1HSP90B1
SCHEMBL24815670 0.77 NLRP3 (0.35) MAPTLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL24814436 0.77 DPP8 (0.42) DPP8DPP9DPP7TRAP1NAMPT
SCHEMBL29986713 0.77 DPP8 (0.42) DPP8DPP9DPP7TRAP1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH DPP8 4457/4885DPP9 4490/4885DPP7 4414/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH DPP8 4457/4885DPP9 4490/4885DPP7 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback